European Journal of Obstetrics & Gynecology and Reproductive Biology
Indicators of fetal and infant health outcomes
Introduction
Fetal and infant health outcomes are important measures of the overall health of a population and of the quality of health care services for mothers and their babies. Further, they are key to monitoring and understanding the impact of changing health care practices. They are necessary, for example, for measuring the extent and impact of antenatal screening and for monitoring the effect of changing practices in the care of extremely preterm babies.
Ten of the PERISTAT indicators measure fetal and infant health outcomes. Five are included on the core list: C1—fetal mortality rate, C2—neonatal mortality rate, C3—infant mortality rate, C4—birth weight distribution, and C5—gestational age distribution. Many of these core indicators are already available in international databases, such those at WHO, EUROSTAT and OECD. PERISTAT recommends that these indicators be computed and presented differently. In particular, it recommends that they be presented by sub-groups to address methodological concerns and make them more specific and sensitive measures of overall health status and health care practices.
In addition to the set of core indicators, the PERISTAT list includes five recommended indicators of infant health: two are recommended for immediate implementation (R1—prevalence of selected congenital anomalies and R2—distribution of APGAR score at 5 min). Three require further work and development of data collection systems before they can be implemented at a European level (F1—causes of perinatal death, F2—prevalence of cerebral palsy and F3—prevalence of hypoxic-ischemic encephalopathy).
This analysis assesses the ability of European countries to produce these indicators and provides an overview of health outcomes according to the information now available.
Section snippets
Methods
The PERISTAT project collected data from the statistical offices and health departments of the participating countries to assess the feasibility of implementing the indicators recommended by its scientific advisory committee. The indicator selection process is described in Zeitlin et al. and the survey is presented in Macfarlane et al. (this issue). All data sources used below are referenced in Appendix A and described in more detail in Macfarlane et al.
Data are presented as numbers and rates
Indicator C1: fetal mortality rate
National data on fetal mortality are available for all countries, as Table 1 shows. The definition used by the PERISTAT project to define fetal deaths was ‘all fetal deaths occurring at or after 22 weeks of gestation’. If countries were not able to provide data on deaths according to this definition, we asked them to provide the information that they routinely collected. Most countries were able to provide data according to this gestational age limit, but others could provide these fetal deaths
Discussion
European countries can provide many of the PERISTAT core and recommended indicators of fetal and infant health and can report most of them by the analytic sub-groups of gestational age, birth weight and plurality. Using these sub-groups makes these indicators both more methodologically sound and more useful for the analysis of overall trends and variations between countries and over time. Most of these data are currently available from national statistical offices and other organisations, but
References (20)
- et al.
The association of Apgar score with subsequent death and cerebral palsy: a population-based study in term infants
J. Pediatr.
(2001) - et al.
Trends in the occurrence, determinants, and consequences of multiple births
Semin. Perinatol.
(2002) - et al.
Algorithms for combining menstrual and ultrasound estimates of gestational age: consequences for rates of preterm and postterm birth
BJOG
(2002) - et al.
Treatment choices for extremely preterm infants: an international perspective
J. Pediatr.
(2000) - et al.
Differences in perinatal mortality and suboptimal care between 10 European regions: results of an international audit
BJOG
(2003) - Office for National Statistics. Mortality statistics: perinatal, infant and childhood, Series DH3 (published annually)....
- SCPE. Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers. Surveillance...
- et al.
Prevention of the first occurrence of neural-tube defects by periconceptional vitamine supplementation
N. Engl. J. Med.
(1992) - et al.
Ascertainment of congenital malformations: a comparative study of two systems
J. Epidemiol. Comm. Health
(1991) - EUROCAT. Surveillance of congenital anomalies in Europe: 1980–1999, Report 8. Ulster: University of Ulster;...
Cited by (112)
Decrease in perinatal mortality after closure of obstetric services in a community hospital in Amsterdam, the Netherlands. A retrospective cohort study
2023, European Journal of Obstetrics and Gynecology and Reproductive BiologyNeurodevelopmental outcomes at 6, 12, and 24 months of age in preterm infants with very low birth weights in Taiwan
2022, Journal of the Formosan Medical AssociationProcess evaluation of the implementation of scorecard-based antenatal risk assessment, care pathways and interdisciplinary consultation: the Healthy Pregnancy 4 All study
2017, Public HealthCitation Excerpt :The results of the European PERISTAT studies revealed that perinatal mortality was substantially higher in the Netherlands compared with other European countries.1,2
Causes and temporal changes in nationally collected stillbirth audit data in high-resource settings
2017, Seminars in Fetal and Neonatal MedicineEffect of developmental care for very premature infants on neurodevelopmental outcome at 2 years of age
2015, Infant Behavior and Development